identification of risk factors of acute hepatitis c virus (hcv) infection in egypt is crucial for developing appropriate prevention strategies. there are few community-based studies on the epidemiology and risk factors of hepatitis c infection in egypt, which could not provide enough information. clear identification of past and current risk factors for infection is of utmost importance so that...

This study was performed to assess the utility of anti-cyclic citrullinated peptide (anti-CCP) antibodies in distinguishing between patients with rheumatoid arthritis (RA) and patients with polyarticular involvement associated with chronic hepatitis C virus (HCV) infection. Serum anti-CCP antibodies and rheumatoid factor (RF) were evaluated in 30 patients with RA, 8 patients with chronic HCV in...

Hepatitis C is caused by the hepatitis C virus (HCV) infection. According to World Health Organization data, 3% of the world population (approximately 170 million people) is infected with HCV; in Poland there are over 700,000. Over 70% of those infected manifest no symptoms in the acute phase of the disease, and in about 70-80% the acute phase progresses into a chronic form. Patients with sympt...

Hepatitis C virus (HCV) affects 130-210 million people worldwide and is one of the major risk factors for hepatocellular carcinoma. Globally, at least one third of hepatocellular carcinoma cases are attributed to HCV infection, and 350000 people died from HCV related diseases per year. There is a great geographical variation of HCV infection globally, with risk factors for the HCV infection dif...

Life Expectancy in PatientsWith Chronic HCV Infection and Cirrhosis ComparedWith a General Population Almost 3millionpeople in theUnited States are chronically infectedwith thehepatitis C virus (HCV).1 The life expectancy of patientswith chronicHCV infection is reduced comparedwith the general population, largely attributable to the development of cirrhosis, liver failure, andhepatocellular car...

Background HCV is the most common chronic blood-borne pathogen in the United States. About 78 percent of individuals who test positive for anti-HCV antibody have detectable hepatitis C virus in their blood, indicating chronic HCV infection. The Centers for Disease Control and Prevention (CDC) estimated that there were 16,000 new cases of acute HCV infection in 2009. HCV infection was associated...

Chronic hepatitis C virus (HCV) infection causes substantial morbidity and mortality in the United States. Testing and treatment of asymptomatic persons might avert progression to more advanced disease. In 1998, CDC published guidelines for HCV testing based on risk factors for infection; however, recent studies indicate that at least one half of all persons living with HCV infection in the Uni...

It has been a mere 10 years since a portion of the genome of the hepatitis C virus (HCV), the infectious agent responsible for most cases of post transfusion hepatitis was sequenced. The discovery in 1989 was followed by the development of tests to detect anti-HCV antibodies, facilitating the screening of potential blood donors. As a result, the number of new cases of HCV infections has decreas...

Abstract Hepatic steatosis is a frequent pathological finding in patients with chronic viral C infection (HCV) and can be independently associated increased alcohol consumption, type 2 diabetes, obesity hyperlipidemia. All these factors lead to the development of hepatic HCV. There are several noninvasive techniques scores used for diagnosing quantifying liver steatosis. Successful eradication ...

Background & Aims: Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease worldwide. The clearance of the HCV is dependent on cytokines control led by genetic. The purpose of this study was to investigate the impact of Lymphotoxin (LT-A) polymorphism at +252 in susceptibility to chronic hepatitis C. Methods: In this case-control study, 120 individuals infected by HCV and ...